Article
Study of CD27, CD38, HLA-DR and Ki-67 immune profiles for the characterization of active tuberculosis, latent infection and end of treatment
22 Jul 2022
Abstract excerpt
Background Current blood-based diagnostic tools for TB are insufficient to properly characterize the distinct stages of TB, from the latent infection (LTBI) to its active form (aTB); nor can they assess treatment efficacy. Several immune cell biomarkers have been proposed as potential candidates for the development of improved diagnostic tools. Objective To compare the capacity of CD27, HLA-DR, CD38 and Ki-67...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
